In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp. | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1No clinically relevant QTc prolongation with ceftibuten or ledaborbactam etzadroxil: concentration-QTc analyses from two phase I studiesJournal of Antimicrobial Chemotherapy · 2026
2Phylogenetic diversification of the PoxtA ribosomal protection determinantJournal of Antimicrobial Chemotherapy · 2026
3Efficacy and safety of switching to once-daily oral doravirine plus raltegravir in virologically suppressed people with HIV-1: a randomized, open-label, multicentre phase 2 study (DORAL)Journal of Antimicrobial Chemotherapy · 2026
4Beyond susceptibility: pharmacokinetic and pharmacodynamic constraints of existing oral antibiotics in extensively drug-resistant typhoid feverJournal of Antimicrobial Chemotherapy · 2026
5Tigecycline-resistant Staphylococcus in waiting pens of a pig slaughterhouse: genomic insights into a food safety alertJournal of Antimicrobial Chemotherapy · 2026
6Assessment of Enterococcus faecalis biofilm response to amoxicillin and ciprofloxacin using a dynamic in vitro pharmacokinetic–pharmacodynamic model of catheter-associated urinary tract infectionJournal of Antimicrobial Chemotherapy · 2026
7The underappreciated role of rifampin in shaping the epidemiology of RT027-like Clostridioides difficile lineagesJournal of Antimicrobial Chemotherapy · 2026
8Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanideJournal of Antimicrobial Chemotherapy · 2026
9Weight-based polymyxin B dosing for mortality and nephrotoxicity: an exploratory dose–response studyJournal of Antimicrobial Chemotherapy · 2026
10Targeting autolysin ATL of Streptococcus suis : structural insights and inhibition by lanreotide acetateJournal of Antimicrobial Chemotherapy · 2026

More from Journal of Antimicrobial Chemotherapy

More from Université Claude Bernard Lyon 1